Neoadjuvant docetaxel (DOC 75) followed by fluorouracil, epirubicin, cyclophosphamide (FEC 100) in primary operable breast cancer: results of a multicenter phase II trial
N. Sato, H. Iwata, N. Masuda, S. Nakamura, N. Yamamoto, K. Kuroi, M. Kurosumi, H. Tsuda, F. Akiyama, M. ToiVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70561-5
File:
PDF, 56 KB
english, 2008